We are live on ! Find out more
NMTC icon

NeuroOne Medical Technologies
NMTC

30 hedge funds and large institutions have $9.18M invested in NeuroOne Medical Technologies in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 2

460% more capital invested

Capital invested by funds: $1.64M → $9.18M (+$7.54M)

67% more funds holding

Funds holding: 18 → 30 (+12)

3.49% more ownership

Funds ownership: 1.04% → 4.53% (+3.5%)

Holders
30
Holders Change
+12
Holders Change %
+66.67%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
–
Closed
2
Calls
$86K
Puts
–
Net Calls
+$86K
Net Calls Change
+$25K

Top Buyers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
+$2.46M
2
SCM
Sio Capital Management
New York
+$2.17M
3
BA
Bard Associates
Illinois
+$1.14M
4
PCM
Perkins Capital Management
Minnesota
+$923K
5
Renaissance Technologies
Renaissance Technologies
New York
+$289K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$83.8K
2
JP Morgan Chase
JP Morgan Chase
New York
-$52
Name Holding Trade Value Shares
Change 		Change in
Stake
BL
1
Bleichroeder LP
New York
$2.71M +$2.46M +666,667 New
SCM
2
Sio Capital Management
New York
$2.39M +$2.17M +587,277 New
BA
3
Bard Associates
Illinois
$1.26M +$1.14M +309,100 New
PCM
4
Perkins Capital Management
Minnesota
$1.02M +$923K +250,000 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$815K +$56.6K +15,318 +8%
Renaissance Technologies
6
Renaissance Technologies
New York
$318K +$289K +78,150 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$237K +$1.75K +475 +0.8%
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
$55K – – –
XT
9
XTX Topco
Cayman Islands
$51.3K +$46.5K +12,606 New
Citadel Advisors
10
Citadel Advisors
Florida
$47.5K +$36.9K +9,985 +593%
State Street
11
State Street
Massachusetts
$40.4K – – –
William Blair & Company
12
William Blair & Company
Illinois
$37.7K – – –
MCM
13
MAI Capital Management
Ohio
$33.9K – – –
Northern Trust
14
Northern Trust
Illinois
$33.2K – – –
WAM
15
Warberg Asset Management
Illinois
$27.1K +$24.6K +6,667 New
JWCA
16
J.W. Cole Advisors
Florida
$25.2K – – –
HF
17
HRT Financial
New York
$13K +$12.4K +3,364 New
CCM
18
Corsair Capital Management
New York
$12.3K +$11.1K +3,016 New
PGAM
19
Princeton Global Asset Management
New Jersey
$11.4K – – –
Raymond James Financial
20
Raymond James Financial
Florida
$10.1K +$9.14K +2,475 New
Morgan Stanley
21
Morgan Stanley
New York
$9.11K +$916 +248 +12%
AQR Capital Management
22
AQR Capital Management
Connecticut
$7.1K +$6.44K +1,745 New
Mariner
23
Mariner
Kansas
$7.1K +$6.44K +1,745 New
TRCT
24
Tower Research Capital (TRC)
New York
$5.85K +$5.31K +1,438 New
Wells Fargo
25
Wells Fargo
California
$904 – – –
1
2

NMTC Hedge Fund Activity: Q2 2025 in Review

30 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q2 2025, worth a combined $9.18M — up 460% from $1.64M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NMTC positions and 2 closed out — a net gain of 12 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Bleichroeder LP, opening a new position worth an estimated $2.46M. The largest seller was Goldman Sachs, exiting entirely with an estimated $83.8K sold.

  • 30 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q2 2025, up from 18 in Q1 2025.
  • Funds reported $9.18M of NeuroOne Medical Technologies stock for Q2 2025, up 460% quarter-over-quarter.
  • 14 funds opened new NeuroOne Medical Technologies positions in Q2 2025 and 2 closed out, a net change of +12 holders.
  • The largest NeuroOne Medical Technologies buyer in Q2 2025 was Bleichroeder LP, an estimated $2.46M added.
  • The largest NeuroOne Medical Technologies seller in Q2 2025 was Goldman Sachs, an estimated $83.8K sold.

Based on aggregated 13F filings for Q2 2025.